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Abstract
PC4 (pheochromocytoma cell-4) is an immediate early
gene related to IFN-’y, the mRNA of which is induced
during the course of neuronal differentiation by nerve
growth factor in the PCi 2 cell line. Here we report that
PC4 mRNA is also expressed in the myoblast C2C1 2 cell
line and is regulated during differentiation; its expression
decreases within 6 h from the onset of differentiation,
attains a minimum after 1 2 h, and returns to basal level
within 36 h. This transient down-regulation of PC4
expression in C2C1 2 myoblasts is prevented by
transforming growth factor 3, a molecule which inhibits
the differentiation of muscle. Sense and antisense PC4
cDNA transfedion strategies in C2C1 2 cells were then
used to clarify the role of PC4 in muscle differentiation.
While no effect was seen by over-expression of PC4,
stable transfedants underexpressing PC4 exhibited a
delay in attaining the differentiated phenotype, with an
impairment of myogenin and myosin expression.
Myogenin was also inhibited in C2C1 2 cells
microinjected with the anti-PC4 polyclonal antibody
A451 . We thus postulate a role for PC4 as a positive
regulator during muscle differentiation.
Introduction
Growth factors induce cellular responses via an activation
of specific patterns of gene expression. The genes induced
early after stimulation are defined as lEGs3 and include the
proto-oncogenes c-los, c-myc, and c-jun, and zinc finger
proteins such as NGFI-A. These lEGs are all induced in
PC12 cells during the neuronal differentiation elicited by
NGF (1-4). c-los, c-fun, and the zinc finger proteins are
transcriptional regulators, and the general idea has emerged
that lEGs are activators of downstream genes, which are
ultimately responsible for the growth factor-dependent cel-
lular changes (4). Although there are indications of such a
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regulatory cascade in NGF-induced PCi 2 cell differentia-
tion (5), further information about the biological relevance
of the above model is still required (6). Moreover, certain
lEGs, which are NGF induced in PCi 2 cells, do not display
any evident features peculiar to transcriptional regulators.
For instance PC4 (pheochromocytoma cell-4), a gene with
partial homology to 1FN-y (7), isolated by differential hy-
bridization from PC12 cells (7, 8) and as a tetradecanoyl
phorbol acetate-induced gene from mouse NIH3T3 cells
(9), is devoid of known transcriptional motifs.
In this study we investigated the possible role of PC4 in
cell differentiation by exploring its expression in the skeletal
myoblast. With respect to PCi 2 cells, this system has the
advantage that a defined set of genes with differentiation-
inducing capabilities has been identified, as well as
polypeptides, such as TGF (10-1 3), that can block the cell
differentiation and the induction of the above genes. In the
myoblast the onset ofdifferentiation is preceded by arrest of
the cell cycle in G1 (14-1 6). The length of time in G1 arrest
is directly proportional to the probability of entering a state
of irreversible withdrawal from the cell cycle (commit-
ment). The latter event is followed by the myoblast fusion
into multinucleated fibers, the myotubes, a major compo-
nent of the adult skeletal muscle morphology (1 5, 1 7). The
prefusion state, characterized morphologically by the elon-
gation and aligning of the cells, coincides with the activa-
tion of muscle-specific regulatory genes, such as Myogenin,
MyoDi, Myf-5, and Myf-6/herculin (1 8-22). These genes,
in turn, activate the expression of structural genes such as
myosin heavy chain (23) and muscle creatine kinase (18,
24) responsible for the adult phenotype of the muscle.
Interestingly, the muscle-specific gene induction can be
reversed by inhibitory growth factors until cell fusion has
occurred (17). The regulatory genes also induce the pro-
gram leading to muscle differentiation in certain nonmuscle
cell lines (1 8, 20, 24), provided that the specific cell line is
permissive (25). The same genes are able to activate their
own expressions as well as those of each other (1 8, 26),
suggesting that via a positive feedback loop, the activation
of a single gene is sufficient to commit the cell to the muscle
phenotype. Regulatory genes are known to control tran-
scription of the target muscle genes by binding to their
control sequences with a basic region. The affinity of this
interaction is affected by the property of an adjacent region,
a putative helix-loop-helix structure, which induces homo-
and heterodimerization between regulatory gene proteins
(for review see Ref. 26).
The mouse skeletal muscle cell line we used, C2C1 2, was
cloned from cells with regenerative potential of the skeletal
muscle (satellite cells). These cells are not transformed and
therefore maintain the character of a primary cell line, and
have the ability to rapidly attain the differentiated pheno-
type (myotubes) after exposure to low serum medium (27).
Here we report that in differentiating C2C1 2 cells the
expression of PC4 mRNA and protein shows a transient
down-regulation that can be suppressed by TGFI3. More-
Fig. 1. PC4 mRNA levels during myoblast differentiation. A Northern blot
of 10 pg of total RNA from C2C1 2 cultures shifted to differentiation medium
(FM) for the times indicated, or from cultures kept under confluent condi-
tions for 36 h in growth medium (C), was hybridized to the PC4 cDNA insert
32P-labeled (about 50 X 106 dpm total, top), to the myogenin probe (30 X
1 06 dpm total, middle), and to giyceraldehyde 3-phosphate dehydrogenase
cDNA as a control of RNA integrity and quantitation (30 X 106 dpm total,
bottom). The autoradiographs were exposed 3 days for the PC4 probe, and
24 and 4 h, respectively, for the myogenin and GAPDH probes.
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over, inhibition of PC4 expression in C2C1 2 cells impairs
the expression of myogenin and that of heavy chain myosin
as well, and delays cell fusion. This suggests that the PC4
protein plays a role in the differentiation of the muscle.
Results
Regulated Expression of PC4 mRNA during Myoblast Dif-
ferentiation. PC4 mRNA, which is present in skeletal mus-
cle (7), was found by Northern analysis to be basally ex-
pressed in the satellite cell-derived C2C12 myoblasts, and
transiently down-regulated during their differentiation, elic-
ted by a shiftto a low serum medium (C2FM; Fig. 1 ). In this
medium a slight increase (30%) of expression occurred
almost immediately (within 1 h), followed by a decrease.
Expression was lowest (one-fourth of the basal level) at 12
h after the onset of differentiation. PC4 mRNA expression
returned to basal levels within 36 h. To verify whether the
transient decrease was a consequence of the removal of
some serum component, we exploited the property of the
myoblast of also differentiating in high serum, provided the
culture density is high enough to allow cell-cell contact. As
seen with the serum deprivation-mediated differentiation,
more than 3-fold reduction of PC4 basal expression was
observed (Fig. 1 , Lane C). This suggested that the decrease
of PC4 mRNA was not a direct consequence of the subtrac-
tion of the serum but more likely of the subsequent events,
such as cell cycle arrest and differentiation. The expression
of myogenin, a key gene in the regulation of muscle differ-
entiation (18), was also evaluated in parallel at various
times. As expected, myogenin mRNA levels increased from
a nondetectable level to a maximum within 36 h, either
after shifting to a low serum (45 times increase) or when
differentiation occurred in high serum (38 times) (Fig. 1,
Lane C; see Ref. 18).
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Fig. 2. Suppression of PC4 mRNA down-regulation by TGFf3. An RNA blot
of 10 pg of total RNA from C2C12 cells shifted to differentiation medium
(FM) for the times indicated, in the presence or absence of 5 ng/ml of TGFI3,
was hybridized to the PC4, myogenin, or GAPDH probes, as indicated, with
specific activities and total dpm comparable to those in Fig. 1.
TGF3 Counteracts PC4 mRNA Regulation during Myo-
blast Differentiation. To further define the relation be-
tween the changes in PC4 expression and cell differentia-
tion, a time course study was carried out on the PC4 mRNA
levels in differentiating C2C12 cells, both in the presence
and absence of TGFj31 (S ng/ml). This molecule is able to
arrest myoblast differentiation by inhibiting the muscle-
specific genes (1 3, 28) without affecting proliferation (10,
1 1 , 1 3). The presence of TGF1 completely inhibited the
decrease of PC4 observed in C2FM after 6 h, and partially
reduced the decrease after 12 h. In fact, at this latter time
point, the expression of PC4 in absence of TGF31 was about
one-fourth ofthe basal level ofexpression, while in cultures
with TGF1, expression of PC4 attained levels comparable
to basal expression (Fig. 2). In parallel, the increase of
myogenin mRNA expression observed 1 2 h after a shift to
C2FM (about 20 times; see also Fig. 1) was also reduced by
TGF1 (6 times), and the normal level of increased expres-
sion was regained only after 72 h (Fig. 2). At this time the
cultures incubated in C2FM with TGF1 showed initial
features of differentiated morphology, such as cell fusion.
C2C12 cultures in C2FM alone, however, started to fuse
within 24 h, reaching the phenotype of elongated myotubes
within 48-72 h. In C2C12 cells kept 12 h in C2FM, a
dose-response curve to increasing concentrations of TGF31
over the down-regulation of PC4 mRNA indicated an IC50
of about 0.2 ng/ml (Fig. 3, A and B). In the presence of
growth medium with high serum (C2GM), TGF1 (5 ng/ml)
does not stimulate the expression of PC4 (data not shown).
Immunolocalization of PC4 Protein during Myoblast
Differentiation. We then sought to determine whether the
PC4 protein expression was down-regulated during muscle
differentiation, and to immunolocalize the protein in the
muscle cell, also in the presence of NGF. In addition to
inducing PC4 in PC12 cells, this neurotrophic molecule
also has a trophic action on skeletal myotubes (29, 30), and
its low affinity NGF receptor has been detected in vivo in
myoblasts (31, 32). We used a polyclonal antibody raised
against PC4, A-451 (see “Material and Methods” and Ref.
33). By indirect immunofluorescence, the PC4 protein was
detected in the cytoplasm of myoblast cultures growing in
C2GM (Fig. 4B) and in the cytoplasm of cultures incubated
in low serum medium for 1 2, 24, and 72 h (Fig. 4, C-E), or
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Fig. 3. Concentration dependence of TGF inhibition on PC4 mRNA decrease. (A) An RNA blot of 1 0 pg of total RNA from control C2C1 2 cells (C2FM, 0 h)
or from cells exposed for 1 2 h to differentiation medium (FM) in the absence or presence of increasing concentrations of TGFJ3, was hybridized to the PC4 probe
(40 X 106 dpm total). (B) Ordinate, relative densities ofthe blot in A, normalized to the GAPDH expression, as the percentage inhibition (%) ofthe PC4 decrease
[0/, of relative densities = (Sample - 12-h C2FM sample without TGF3)/(O-h C2FM sample - 12-h C2FM sample without TGFf3) X 1001; abscissa, logarithm of
the concentration.
Fig. 4. Cellular localization and
expression of PC4 in C2C1 2 skel-
etal myob(asts and myotubes. The
antigen was revealed by FITC
staining after incubation with non-
immune serum as a control (A) or
with affinity-purified A451 serum
(B-F). B, Undifferentiated grow-
ing myoblasts; C. myoblast ex-
posed for 1 2 h to FM; 0, 24 h to
FM; E and F, fully differentiated
myotubes after 72 h in FM without
or with NGF, respectively. Preab-
sorption of affinity-purified A451
with nonrecombinant -ga(actosi-
dase protein had no effect on PC4
staining in C2C12 cells (not
shown). Bar, 40 pm.
for 72 h in low serum medium plus NGF (200 ng/ml; Fig.
4F). We observed that in parallel with the changes in the
mRNA levels of PC4 (Figs. 1-3), the protein staining de-
creased 1 2 h after the shift to C2FM, followed by a gradual
return to the initial level within 72 h. At this time the cells
presented the differentiated morphology of elongated and
polynucleated myotubes (not apparently affected by NGF).
Thus, NGF treatment did not apparently influence the ex-
pression and localization ofthe PC4 protein in myoblasts as
judged by immunofluorescence staining with A451 . (Also,
in C2C1 2 cells allowed to differentiate in the presence of
NGF 1100 ng/mll for 36 h, no change was observed in the
pattern of PC4 and myogenin mRNAs induction, data not
shown).
Inhibition of Myogenin and Myosin Induction in PC4-
deprived Myoblasts. To further assess the role of PC4 in
muscle differentiation, we then stably transfected the full-
length PC4 cDNA in the sense or antisense orientation into
C2C1 2 cells, under the control of the 3 actin promoter in
the vector pHAPr-1-neo [pBAP-neo-PC4 (34)J. From 6 X
1 0 cells transfected with each type of construct, we ob-
tamed several neomycin-resistant clones. One of them, ex-
pressing PC4 mRNA in the sense orientation (S4), and one
clone expressing PC4 mRNA in the antisense orientation
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Fig. 5. Expression ofthe PC4 RNA and protein in the C2C12 clones stably transfected with pBAP-PC4. (A) Eight pg oftotal RNAfrom C2C12 control cells (C2)
or transfected with the pBAP-neo-PC4 vector in the sense (54) or antisense orientation (A 16) were extracted, blotted on nitroceliulose filters, hybridized with the
complementary RNA probe, and analyzed by autoradiography. In clone Al 6 the antisense RNA was revealed by sense-transcribed PC4 probe, while in S4 clone
and C2C1 2 cells the sense RNA was detected by an antisense probe (see “Materials and Methods”). The probes had comparable specific activities (60 X 10
dpm/mg ofcDNA template), and the exposure time was 24 h. (B) Immunofluorescent (FITC) staining ofthe PC4 protein after incubation with the A-451 antiserum
in C2C12 parental cells (C2), or stably transfected with the pBAP-neo-PC4 vector in the sense (54) or antisense orientation (A16; corresponding phase contrast
field on the right), or transfected with the pBAP-neo vector ( VB). FITC staining was also performed after incubation with nonimmune serum as a control (P1). Bar,
60 pm.
(Al 6), were chosen for further study. The PC4 sequences
stably transfected in the C2C1 2 cell clones were detected as
a transcript of about 1 .9 kilobases (Fig. 5A), consistent with
an expected length of 1438 nucleotides (the Baml-HindIlI
fragment of PC4 cDNA containing the complete coding
region), plus about 450 nucleotides of the untranslated
region of the vector pBAP-neo (34). Western blot analysis
indicated that the 54 clone produced several times more
PC4 protein than did control cells (not shown).
In these transfectants we monitored the level of the PC4
protein by immunofluorescence (Fig. SB) with the anti-PC4
antibody A-451 . As expected, the expression of the PC4
protein was higher in the 54 clone than in a clone of cells
sham transfected with the pBAP-neo vector (VB), and al-
most undetectable in Al 6 (Fig. 5B). These different levels of
expression in the sense- and antisense-transfected cells
were also maintained when the cultures were shifted to
C2FM (data not shown; see also Ref. 34).
We then checked the effects of altered levels of PC4
protein on cell differentiation by analyzing the levels of
myogenin and myosin heavy chain proteins and by observ-
ing cell fusion. Myogenin isa key regulator gene of muscle
differentiation (18) also required for muscle maturation in
vivo (35, 36), while the myosin heavy chain is a structural
protein present in the developing and adult muscle, the
expression of which is induced in differentiating cultured
cells (23, 37) and is regulated by myogenin.
Immunoblot analysis of the myogenin protein levels at
various times after shifting the cultures to C2FM showed
that after 48 h myogenin was maximally increased in the
sense (54) and control cultures [control C2C1 2 cells and the
pBAP sham-transfected clones (see Fig. 6; Table 1)] and
almost undetectable in the A16 clone (Fig. 6; Table 1).
Similarly, an increase of myosin protein levels was ob-
served after 48 h in C2FM, only in the sense and control
clones (Fig. 6; Table 1).
The stable expression of antisense PC4 RNA and the inhi-
bition of myogenin protein induction during differentiation
was correlated in three other C2C1 2 clones too, called A7, Al,
and A3 (see Fig. 7; Table 1), transfected with vectors consti-
tutively transcribing the PC4 insert Baml-HincAII in the anti-
sense direction under the control of other promoters, respec-
tively SV4O (vectors pCDL-SRa and pSV2; Refs. 38 and 39) or
the cytomegalovirus promoter (vector pRc-CMV). These
clones presented, in common with Al 6, an impairment of
myosin protein induction, measured after 48 h of exposure to
C2FM. Sham-transfected clones showed normal increases in
myogenin or myosin expression (Fig. 7; Table 1).
Thus, these results indicate that the inhibition of myoge-
nm expression, as well as that of myosin, is genuinely
dependent on the expression of antisense PC4 RNA, irre-
spective of the type of vector used.
Morphological analysis by phase contrast microscopy
indicated that cultures of clones transfected with antisense
construct kept 48 h in C2FM presented less cell fusion than
did cultures transfected with the vector or the sense con-
struct. In Fig. 8A are shown clones Al 6, VB, and 54. However,
all the clones attained the fully differentiated phenotype when
46 -
myog :::
30 -
myos -.
97 -
,.*Ji. #{149}
Cell Growth & Differentiation 163
C2 54 VB C2 A16
hours ‘0 16 30 48”0 16 30 48’0 16 30 48”O 16 30 48”O 16 30 48’
69 -
Fifl. 6. Immunohlot analysis of
the myogenin and myosin pro-
teins in the C2C1 2 clones stably
transfected with pBAP-PC4 and
exposed to C2FM for the times
indicated. Equal amounts of
proteins were loaded onto 12
(myog) or 6/ (myo) SDS-poly-
acrylamide gel, blotted on nitro-
cellulose filters, and incubated
with the mouse mAbs against
myogenin or myosin. The signal
was detected by incubation
with alkaline phosphatase-con-
jugated goat anti-mouse, fol-
lowed by colorimetric develop-
ment. The clones are indicated
as in Fig. 58. Ordinate, protein
molecular weight standards in
thousands.
Table 1 Analysis of the effects of under- or overexpressing PC4 on myogenin and myosin levels in C2C1 2 cells
Clone
name
Vector
transfected
. .Orientation
of PC4 insert
PC4 RNA’
(sense or
antisense)
PC4
protein”
.
Myogenin
induction )“/(‘
.
Myosin
induction “h’)’
S4 pBAP-neo-PC4 Sense
() 29
VB pBAP-neo Vector alone ND. #{247}++ 100 100
VB-2 pBAP-neo Vector alone ND. +++ 91 95
A16 pBAP-neo-PC4 Antisense +++ --- 2 1
VR SRa Vector alone ND. +++ 100 100
A7 SRa-PC4 Antisense ++ - 35 10
V2 pSV2 Vector alone ND. +++ 100 100
Al pSV2-PC4 Antisense +)+) - 40 12
VM pRc-CMV Vector alone ND. +++ 100 100
A3 pRc-CMV-PC4 Antisense + + 76 14
.‘ Relative values ofthe vector’s promoter-driven expression of PC4 RNA, measured by Northern analysis with riboprohes complementary to the senseor antisense
sequence of PC4.
F, Relative PC4 protein expression, revealed by immunofluorescence staining.
( Myogenin and myosin protein levels ofthe transfected cultures exposed 48 hours to C2FM, as detected by immunoblot analysis of the lysates. The amount of the latter
two proteins was measured for each clone by densitometric scanning of the immunoblots and calculated as the percentage of the signal observed in the corresponding
control clone (transfected with the same vector without PC4 insert). The clone pBAP was considered as control of pBAP-neo-PC4 transfected clones. The clones analyzed
represent those detected by screening about 30 neomycin resistant clones for each type of vector transfected (about 6 x 1 0 cells per transfection).
 100-200%; +++, 75-l00%; +)+), 25-35%,; ++, 35-50/,,; -, 5-10/,,; +, 10-25%; ---, 0%; ND, not detectable.
exposed for longer periods to C2FM (Fig. 88, cultures man- This technique permits unequivocal identification of the
tamed 144 h in C2FM). In these latter conditions in clone Al 6, microinjected cells and thus directly correlates the micro-
the expression of myogenin, myosin, and PC4 proteins (virtu- injection of antibodies to the cellular effects with no uncer-
ally absent after 48 h in C2FM) was detectable (Fig. 8, C and tainty. Therefore, we conclude that the activity of the PC4
0). This further indicates a correlation between the expression protein in some way plays a part in the induction of
of PC4 and that of myogenin and myosin. myogenin protein during myoblast differentiation. This
We then attempted to verify these findings with an inde- suggests that PC4 might be necessary for normal muscle
pendent approach, inhibiting the activity ofthe endogenous development.
PC4 protein in C2C1 2 cells by microinjecting anti-PC4
affinity-purified antibody. C2C1 2 cells were injected in the
cytoplasm, refed after 4 h with C2FM, and allowed to Discussion
differentiate by exposure to C2FM for 48 h. The cells in- Functional Significance of PC4 in the Differentiating Myo-
jected with A45l antibody expressed myogenin with sig- blast. We have shown here that expression of the PC4
nificantly lower frequency than did cells injected with con- gene, which is NGF inducible in the PCi 2 cell line, de-
trol antibodies (Fig. 9; Table 2). creases transiently in differentiating myoblasts, and that the
A7 VS A] VM A3
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inhibition of its expression impairs the induction of myo-
genin and myosin gene expression. Levels of PC4 expres-
sion were similar in growing and fully differentiated cul-
tures, and in cultures the differentiation of which was
impaired by TGFf3. On the other hand, TGFf3 counteracted
the transient down-regulation of PC4 expression. Since
TGFf3 prevents myoblasts incubated in low serum medium
from arresting the cell cycle (1 1 ), these latter observations
point to an association between the transient down-regula-
tion and either the proliferative arrest that precedes differ-
entiation or the initial phase of the differentiation itself.
However, we should consider that in our hands TGFI3
treatment delayed but did not prevent myogenin expression
(which attained high levels within 36 h) and, thus, myoblast
differentiation. Therefore a transient decrease of PC4,
which was completely inhibited by TGFf3 treatment, does
not appear to be required for differentiation. Furthermore,
despite the absence in both the sense and antisense PC4-
transfected clones of a transient down-regulation of the PC4
protein (expressed respectively at a steadily high or low
level), only the clones with a low level of PC4 protein had
impaired myogenin regulation. Such impairment was also
observed in cells deprived of PC4 protein by microinjection
of anti-PC4 antibodies shortly before inducing differentia-
tion. Thus, the presence of PC4, rather than its transient
decrease, might be a requirement for myogenin induction.
In clones with reduced expression of PC4 and myogenin,
myosin induction was impaired as well. Since heavy chain
myosin is a structural protein marker for myoblast differen-
tiation, this indicates that the inhibition of PC4 expression
negatively affects not only myogenin induction but also the
Fig. 7. Expression of PC4 anti-
sense RNA, PC4 protein, and
myogenin and myosin proteins in
C2C1 2 clones stably transfected
with pCDL-SRa, pSV2, and pRc-
CMV vectors bearing antisense
PC4 cDNA. PC4 antisense RNA
(by Northern analysis; A), PC4
protein (by immunofluorescence
staining; B), and myogenin and
myosin proteins (by immunoblot;
C), were detected as described in
Figs. 5 and 6. Clones VR, V2, and
VM were transfected with vectors
(pCDL-SRe, pSV2, and pRc-CMV,
respectively) without insert;
clones A7, Al , and A3 were trans-
fected with the corresponding
vectors bearing PC4 antisense-ori-
ented cDNA. A) Arrow, PC4 an-
tisense RNA; exposure time of the
autoradiographs was 24 h. (B)
Bar, 70 pm. Myogenin and myo-
sin protein were analyzed in cul-
tures kept 48 h in C2FM (C).
process of differentiation. Indeed, we detected morpholog-
ically a reduced extent of differentiation. Such effect is
possibly in relation to the inhibition of myogenin. However,
the antisense-transfected clones, which after 48 h in C2FM
presented reduced myogenin and myosin levels, had not
lost the ability to fuse and, eventually, to fully differentiate
after long exposure to C2FM. In fact, in clone A16 we
observed that after 1 44 h in C2FM the cellular fusion and
the induction of myogenin and myosin, as well as the
expression of PC4, did not significantly differ from the
control clone. While attainment of differentiation can be
explained by the restorationof myogenin levels,thisin turn
might be consequent to the recovered expression of PC4.
We speculate that this latter event can be due to a feedback
up-regulation of the endogenous PC4 promoter activity.
Alternatively, it could be supposed that cells expressing
PC4 antisense are prevented from differentiating only until
the ongoing proliferation has diluted the antisense vector
molecules in the cellular progeny to a number insufficient
to inhibit endogenous PC4 mRNA. Such a hypothesis
would assume that the vector remains episomic.
In our view, in functional terms, adequate levels of PC4
might be necessary at the moment when the cell receives
the signal to differentiate, and myogenin induction is de-
layed until such levels are reached. On the contrary, the
decrease of PC4 expression which rapidly follows the onset
of differentiation could be a marker of the arrest of prolif-
eration or differentiation. Furthermore, the ensuing restora-
tion of the basal levels of PC4 appears to be unnecessary for
myogenin induction, which begins before this restoration
occurs (see Fig. 1).
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Fig. 8. Morphology of C2C1 2
cells transfected with antisense
PC4 cDNA. Phase contrast micro-
graphs of pBAP ( VB), Al 6, and S4
clones cultured 48 h in C2FM (A)
and 144 h in C2FM (B). Bar, 250
pm. (C) Levels of myogenin and
myosin proteins (by immunoblot,
in clones pBAP and A16 cultured
in C2FM for the times indicated);
(0) Levels of PC4 protein in clone
A16 (by immunofluorescence
staining using the A-45l anti-
serum in cultures kept 48 h )cor-
responding phase contrast field
below) and 144 h in C2FMJ. )D)
Bar, 100 pm. The procedures
were as described above (Figs. 5
and 6).
Cellular Localization and Function of PC4 in Muscle In
C2C1 2 cells the PC4 protein appears to be localized in the
cytoplasm. In undifferentiated PCi 2 cells PC4 is also clearly
restricted to the cytosol. However, as the PCi 2 cultures
reach a state of advanced neuronal differentiation elicited
by NGF, the PC4 protein becomes localized in the nucleus
(33). Several examples are known of proteins imported from
the cytoplasm to the nucleus depending on extracellullar
signals or biological cues [e.g., the IFN-stimulated gene
factor 3a translocates to the nucleus on activation by IF N-a
(ref. 40; for review see Refs. 41 and 42)]. The absence of
nuclear translocation of PC4 in C2C12 cells, either differ-
entiating or treated with NGF, might indicate that the trans-
location in PC12 cells is cell type specific. We cannot
however completely rule out the possibility of a hormone-
dependent mechanism common to both cell types; in fact,
S S
‘ . 
.. .
i.
166 PC4 Function in Muscle Differentiation
4 D. Guardavaccaro and F. Tirone, unpublished results.
.
‘- .4
-. 

Ak
5.
qj-*.A B
*
Fig. 9. Analysis of myogenin ex-
pression in C2C12 cells microin-
jected with anti-PC4 antibody.
C2C12 cells growing on cover-
slips in C2GM were microinjected
in the cytoplasm with control lgG
(A, C, and E) or with A451 (B, D,
and F). Four h later C2FM medium
was added and left for 48 h (with
an intermediate refeeding after 24
h). Thereafter, cells were fixed as
described and processed for im-
munofluorescence. Each cover-
slip was double stained with goat
anti-rabbit tetramethylrhodamine
isothiocyanate-conjugated anti-
bodies to visualize cells succes-
fully microinjected (A and B),
and with anti-myogenin [mouse
monoclonal anti-myogenin/goat
anti-mouse FITC-conjugated anti-
bodies (C and 0)1. The corre-
sponding phase contrast images
are presented (Eand F). The fields
shown are representative of exper-
imental data (see Table 2). Bar,
40 pm.
the lack of nuclear translocation in C2C1 2 cells might be
dependent on the absence of appropriate signal transduc-
tion pathways for NGF. This is suggested by the inability of
NGF to influence PC4 (and myogenin) mRNA expression in
this cell system.
In speculating about the mechanisms underlying the reg-
ulation of PC4 in myogenesis, the localization of PC4 in the
cytoplasm argues against direct effects on gene regulation
in the nucleus; indeed, sequence analysis of the PC4 pro-
tein does not indicate the presence of any motif involved in
control of transcription such as the helix-loop-helix motif of
the muscle-specific regulatory proteins (26). However, in
consideration of the effects on myogenin expression, it is
possible that PC4 exerts a transcriptional regulation through
unknown motifs or by indirect mechanisms, e.g., by influ-
encing the activity of transcription regulators. The possibil-
ity that the PC4 protein is transiently associated to the
myoblast plasma membrane, as observed in PC1 2 cells by
electron microscopy (33), should be investigated. In such a
case, the function of PC4 could be related to the transduc-
tion of signals across the plasma membrane, at the onset of
the differentiative process. However, at this point it seems
unlikely that PC4 could exert its biological actions by
means of an autocrine mechanism, as is the case for inter-
ferons (7), considering that thus far we have been unable to
detect any secretion of the protein in the cell medium (33).
Interestingly, we observed that myogenin induction is im-
paired by microinjecting antibodies directed not only
against the amino-terminal region of PC4, such as A45l,
but also against the carboxy-terminal region, such as the P1
antibody (see ref. 33)#{149}4This suggests that the correlation
observed between PC4 levels and myogenin induction
might depend on molecular events requiring the integrity of
the entire PC4 protein molecule (e.g., protein conforma-
tion).
Functional Differences in Myogenesis between PC4 and
Other NGF-inducible Genes Interestingly, the expression
of other genes induced by NGF in PCi 2 cells is down-
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Table 2 Effect of a nti-PC4 antibody nj ection on myogenin induction
Control immunoglobulin Anti-PC4 immunoglobulin
Experimenr’ No. of injected
cells analyzed”
No. of myogenin-
positive cells
Myogenin
induction (%)‘
No. of injected
cells analyzed”
No. of myogenin-
positive cells
Myogenin
induction (%Y
I
II
III
69
33
37
35
9
16
51
27
43
72
55
98
26
8
18
36
15
18
a Performed as described in Fig. 9.
b As visualized by detection with goat anti-rabbit tetramethylrhodamine isothiocyanate-conjugated antibodies.
C Mean ± SE = 40.3 ± 7.0.
d Mean ± SE = 23.0 ± 6.5; P < 0.05 vs. control immunoglobulin (Student’s paired t test).
regulated in the differentiating skeletal myoblast, namely
the proto-oncogenes c-fun, c-myc, and c-los (3, 43-46),
which all have the ability to inhibit the differentiation of the
muscle cell (and, in the case of c-los, probably also of the
PC1 2 cells; see Ref. 47), albeit with different mechanisms.
c-myc inhibits differentiation probably by stimulating cell
proliferation and without directly affecting the regulation of
MyoD (48), while c-jun and c-los act by blocking the ex-
pression and function of MyoDi and myogenin through a
direct interaction between the leucin zipper domain (at
least in the case of c-fun) and the helix-loop-helix region of
MyoD (43, 49, 50). Unlike PC4, the mRNA levels of the
proto-oncogenes are permanently down-regulated in differ-
entiated muscle cells (43-45), with the c-los and c-myc
proteins undergoing nucleus-cytoplasm exchange in all
the cell types tested (51 ), including the muscle cell.5 It
appears, therefore, that PC4 has a peculiar profile, different
from the other NGF-inducible genes regulated during mus-
cle differentiation. In fact, PC4 does not inhibit differentia-
tion but appears to be necessary for the correct expression
of the differentiated phenotype of the muscle cell.
Definition of the mechanisms through which PC4 acts
promises an insight into the process of muscle differentia-
tion. It will also be important to assess whether the involve-
ment of PC4 in differentiation is muscle specific or also
occurs in neuronal differentiation, as it has been suggested
(7).
Materials and Methods
Cell Culture. C2C1 2 cells from the 16th passage were ob-
tamed from H. Blau (Stanford University, Stanford, CA) and
propagated in C2GM (see above) in a humidified atmo-
sphere of 12% CO2 at 37#{176}C.Differentiation was obtained
by shifting the cultures to C2FM (see above), with a change
of medium every 24 h. FCS and horse serum were from
Hyclone Laboratories (Logan, UT). NGF (1 00 ng/mI) and
porcine TGF1 (British Biotechnology, Oxon, UK) were
added to the cell cultures in the logarithmic phase of growth
(about 40% confluent).
RNA Isolation and Analysis. Cytoplasmic RNA for
Northern analysis was obtained from C2C1 2 cell cultures
by homogenization in 4 M guanidine thiocyanate, followed
by extraction with phenol-chloroform (52). The RNA was
separated electrophoretically on 1 .2#{176}Ioagarose/2.2 M form-
aldehyde gel, transferred to nitrocellulose filters, hybridized
to a Pstl-PstI fragment 0.8 kilobase long, and excised from
the pcD-PC4 vector (7) and to a rat myogenin probe of 1 .6
kilobases obtained by EcoRI digestion of the vector pEMS-
myogenin (1 9). The probes were recovered after gel sepa-
ration by Geneclean II (BlO 101, La Jolla, CA); 32P-labeled
with the hexamer primers procedure (53); and hybridized to
filters in 50% formamide, 5X SSC (1 50 mt’.’i NaCI and 1 5 mt’i
Na citrate, pH 7), 5X Denhardt’s (1% Ficoll, 1% polyvi-
nylpyrrolidone, 1% bovine serum albumine), 0.1% SDS,
and 0.5 mg/mI salmon sperm DNA for 20 h at 42#{176}C.Then
probes were washed at 55#{176}Cin 0.1 X SSC and 0.1 % SDS for
1 h. The integrity and the amounts of the RNAs were
checked either by hybridizing the filters to the cDNA
GAPDH or by ethidium staining of the gel. The intensity of
the hybridization bands of the autoradiographs was quan-
tified by an EPA 3000 densitometer (Sanwatsusho, Tokyo,
Japan) in the linear range ofthe film. The intensity values of
the sample, where indicated, were normalized to the cor-
responding values of GAPDH or ethidium bromide. The
RNA probe for the analysis of the transfected clones was
synthesized from a pGEM-3 vector (Promega, Madison, WI)
bearing a Baml-HindlIl fragment of the PC4 cDNA (pGEM-
PC4), either in the sense or antisense orientation, linearized
by BamHI, and transcribed by SP6 polymerase in the pres-
ence of [a-32P]rCTP, with a transcription kit from Promega.
Filters were hybridized in a 50 mivi sodium phosphate buffer
at pH 6.5 with 50% formamide, 5X SSC, 8X Denhardt’s,
0.1% SDS, 0.25 mg/mI salmon sperm DNA, and 0.5 mg/mI
of yeast RNA, for 20 h at 60#{176}C.They were washed at 65#{176}C
in 0.1 X SSC and 0.l% SDS for 1 h.
Expression of PC4 in Escherichia coil and Generation of
Anti-PC4 Polyclonal Antibody. The antibody used, A451,
had already been produced and characterized (33). Briefly,
a fusion protein of 3-gaIactosidase with part of the PC4
protein (amino acids 52-144) was obtained by subcloning
the PstI-Pstl fragment (nucleotides 299-577) from the cod-
ing region of PC4 cDNA in the Pstl site of the vector pUEX-3
(Amersham, Little Chalfont, England). The resulting protein
was expressed in E. co/i, purified by elution from an SDS
polyacrylamide gel onto which the bacteria lysate had been
loaded, and used as immunogen in rabbits. The immune
serum was then precipitated by addition of saturated am-
monium sulfate (40% final concentration), dialyzed against
PBS, and affinity purified through a column of cyanogen
bromide-activated-Sepharose 4B resin conjugated to f3-ga-
lactosidase-PC4 protein according to the manufacturer’s
instructions (Pharmacia, Uppsala, Sweden; see Ref. 33).
The buffer was exchanged with PBS and the antibody was
concentrated with a Centricon 3 ultrafilter (Amicon, Dan-
vers, MA). The antibody used for microinjection before the
passage through Sepharose 4B resin conjugated to 3-gaIac-
tosidase-PC4 protein was additionally passed over a similar
column conjugated to purified f3-galactosidase protein.
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Microinjection was performed with the antibody at a final
concentration of4 mg/mi in 0.5 x PBS. The specificity of the
affinity-purified A45l antibody was analyzed by comparing
the size and the tryptic digestion pattern of immunoprecipi-
tates from whole cell lysates and from in vitro translated
PC4 protein (33).
Control antibodies used for microinjection were immu-
noglobulins purified from nonimmune rabbit serum by af-
finity chromatography with protein A-agarose CL 4B resin,
as per manufacturer’s instructions (Pharmacia). The buffer
was exchanged with PBS (0.5 X) and the antibody was
concentrated with Centricon 3, to 4 mg/mI.
Immunofluorescence Microscopy. Cells grown on poly-
lysine-coated coverslips were washed 3 times with PBS,
fixed for 10 mm at room temperature in PBS containing 4%
paraformaldehyde, and then permeabilized with 0.2% Tn-
ton in 0.1 M Tnis-HCI (pH 7.5). After a PBS wash, the cells
were incubated for 60 mm at room temperature with the
primary affinity-purified antibody, A45l, diluted in PBS.
After 2 washes in PBS the cells were incubated for 30 mm
at room temperature with FITC-conjugated (Myles-Yeda,
Rehovot, Israel) goat anti-rabbit. Immunofluorescence was
performed on a Leitz Dialux 22 microscope.
Calcium Phosphate Transfection. Cultures of C2C1 2
cells in 100-mm dishes containing approximately 6 X l0
cells were transfected by calcium phosphate precipitation
(54). Vectors used for transfections were the -actmn pro-
moter-dniven vector pBAP-neo (34), the SV4O promoter-
driven vectors pCDL-SRa (38) and pSV2 (39), and the hu-
man cytomegalovmrus promoter-driven vector pRc-CMV
(lnvitrogen, San Diego, CA). These vectors were transfected
either alone or bearing the BamI-HindIlI fragment of PC4
cDNA in the sense (only in the case of pBAP-neo) or anti-
sense orientation. This fragment was obtained by excision
from the pcD-PC4 cDNA (7) and subcloned in Sail site of
each of these vectors, with the exception of pRc-CMV. In
this latter vector the fragment BamI-HindlII of PC4, ob-
tamed from the vector pGEM-3-PC4 (as HindllI-SmaI frag-
ment within the poly-linker; see Ref. 33), was subcloned in
the HinciIll-Xbal sites after blunt ending the XbaI site. Forty-
eight h after transfection the cultures were transferred for
selection into C2GM containing 800 mg/mI of G41 8
(GIBCO, Grand Island, NY), the resistance of which was
provided by the neomycin resistance gene present (under
control of the SV4O early promoter) in the vectors pBAP-
neo, pRc-CMV, and pSV2 neo (this latter cotransfected with
either pCDL-SRa or with pSV2 vectors; see Ref. 39). After
1 0 days, individual colonies were isolated and propagated
into stable cell lines (about 30 per transfection of 6 X 1 0
cells with each sense or antisense construct) and analyzed
for the expression of antisense PC4 RNA and PC4 protein.
The clones studied represent all those positive for the
expression of antisense (or sense) PC4 mRNA.
lmmunoblot Analysis. Transfected and control clones
( i.e., sham transfected with the vector alone) were plated to
the same density of 1 x 106 cells in 60-mm plates and
utilized after 24 h for the differentiation experiments by
exposure to C2FM for the time indicated. Then transfected
C2C1 2 cell cultures were harvested, centrifuged, and re-
suspended in loading buffer (50 misi Tnis-HCI, pH 6.8-2%
SDS-l 0 mM DTT-l mM phenylmethylsulfonyl fluonide-l mit
Ieupeptin) and heated for 5 mm at 1 00#{176}C.Aliquots contain-
ing equal amounts of protein were analyzed by SDS/1 2 (for
myogenin detection) or 6% (for myosin detection) PAGE.
After electrophoresis, proteins were electrophoretically
transferred to nitrocellulose (4 h for the myogenin blot and
overnight for myosin) at 1 20 mA in 24 mti Tnis-HCI, pH
8.0-1 66 mM glycine-20% methanol. The filters were then
incubated for 3 h with either a mouse monodonal anti-
myogenin (55) or anti-heavy chain myosin antibody (MF-
20; see Ref. 43). As a secondary antibody, alkaline phos-
phatase-conjugated goat anti-mouse IgG (Pierce, Rockford,
IL) was used following the manufacturer’s instructions.
Microinjedion. For microinjection, C2C1 2 myoblasts
were grown on circular coverslips (1 0 mm diameter) in
35-mm Petni dishes containing 10 cells in C2GM. The cells
were microinjected by an Eppendorf automatic microinjec-
ton (Model 5242; Eppendorf, Hamburg, Germany) as de-
scnibed (56) with the use of glass micropipettes (femtotips;
Eppendorf), with a plastic tip for back filling (microloaders;
Eppendorf). Each cell localized within a circular mark on
the underside ofthe coverslip was injected in the cytoplasm
for 0.5 5 at a constant pressure of 100 hPa. With these
conditions we estimate that the injection volume was about
1 0% of the volume of the cell. Four h after injection each
culture was washed with PBS, shifted to C2FM, and ana-
lyzed after 48 h by double immunofluonescence labeling for
the presence of the antibody injected and of myogenin. The
protocol was as described above for PC4 detection, except
that the antibody injected (either A45l or control) was
visualized by goat anti-rabbit tetramethylrhodammne iso-
thiocyanate-conjugated antibodies (Caltag Laboratories, S.
Francisco), while myogenin was revealed by a mouse
monoclonal anti-myogenin (55), followed by goat anti-
mouse FITC-conjugated antibodies (Sigma Chemical Co.,
St. Louis, MO)
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